References
- Martin W. R. Opioid antagonists. Pharmacol. Rev. 1967; 19: 463–521
- Martin W. R., Eades C. G., Thompson J. A., Huppler R. E., Gilbert P. E. The effects of morphine- and nalorphine-like drugs in the nondependent and morphine-dependent chronic spinal dog. J. Pharmacol. Exp. Ther. 1976; 197: 517–532
- Lord J. A.H., Waterfield A. A., Hughes J., Kosterlitz H. W. Endogenous opioid peptides: Multiple agonists and receptors. Nature 1977; 267: 495–499
- Chang K. J., Cuatrecasas P. Multiple opiate receptors. J. Biol. Chem. 1979; 254: 2610–2618
- Snyder S. H., Goodman R. R. Multiple neurotransmitter receptors. J. Neurchem. 1980; 35: 5–15
- Chang K. J., Hazum E., Cuatrecasas P. Novel opiate binding sites selective for benzomorphan drugs. Proc. natl. Acad. Sci. (Wash.) 1981; 78: 4141–4145
- Kosterlitz H. W., Paterson S. J., Robson L. E. Characterization of the K-subtype of the opiate receptor in the guinea-pig brain. Br. J. Pharmac. 1981; 73: 939–949
- Pfeiffer A., Herz A. Demonstration and distribution of an opiate binding site in rat brain with high affinity for ethylketocyclazocine and SKF 10,047. Biochem. Biophys. Res. Commun. 1981; 101: 38–44
- Lemaire S., Magnan J., Resoli D. Rat vas deferens: A specific bioassay for endogenous opioid peptides. Br. J. Pharmac. 1978; 64: 327–329
- Schulz R., Faase E., Wüster M., Herz A. Selective receptors for ß-endorphin on the rat vas deferens. Life Sci. 1979; 24: 843–850
- Oka T., Nesishi K., Suda M., Matsumiya T., Inazu T., Ueki M. Rabbit vas deverens: a specific bioassay for opioid K-receptor agonists. Eur. J. Pharmacol. 1981; 73: 235–236
- Wüster M., Schulz R., Herz A. Specificity of opioids towards the μ-, δ- and ε-opiate receptors. Neurosci. Lett. 1979; 15: 193–198
- Schulz R., Wüster M., Krenss H., Herz A. Lack of cross-tolerance on multiple opiate receptors in the mouse vas deferens. Mol. Pharmacol. 1980; 18: 395–401
- Schulz R., Wüster M., Krenss H., Herz A. Selective development of tolerance without dependence in multiple opiate receptors of mouse vas deferens. Nature 1980; 285: 242–243
- Wüster M., Schulz R., Herz A. Multiple opiate receptors in peripheral tissue preparations. Biochem. Pharmacol. 1981; 30: 1883–1887
- Schulz R., Wüster M., Herz A. Pharmacological characterization of the ε-opiate receptor. J. Pharmacol. Exp. Ther. 1981; 216: 604–606
- Schulz R., Wüster M., Rubini P., Herz A. Functional opiate receptors in the guinea-pig ileum: Their differentiation by means of selective tolerance development. J. Pharmacol. Exp. Ther. 1981; 219: 547–550
- Wüster M., Rubini P., Schulz R. The preference of putative pro-enkephalins for different types of opiate receptors. Life Sci. 1981; 29: 1219–1227
- Chavkin C., Hames I. F., Goldstein A. Dynorphin is a specific endogenous ligand of the kappa opioid receptor. Science 1982; 215: 413–415
- Wüster M., Schulz R., Herz A. The direction of opioid agonists towards μ-, δ- and ε-receptors in the vas deferens of the mouse and the rat. Life Sci. 1980; 27: 163–170
- Agnati L. F., Fuxe K., Zini I., Lenzi P., Hoekfelt T. Aspects on receptor regulation and Iso-receptor identification. Med. Biol. 1980; 58: 182–187
- Wolozin B. L., Pasternak G. W. Classification of multiple morphine and enkephalin binding sites in the central nervous system. Proc. Natl. Acad. Sci. USA 1981; 78: 6181–6185
- Pfeiffer A., Herz A. A subclassification of K-sites in human brain by use of Dynorphin 1–17. Neuropeptides 1981; 2: 89–97
- Stautner C., Wüster M., Schulz R., Herz A. A differential interaction of putative μ-selective agonists with opiate binding sites in rat brain, submitted.
- Wüster M., Schulz R., Herz A. Opiate activity and receptor selectivity of dynorphin 1–13 and related peptides. Neurosci. Lett. 1980; 20: 79–83